Yersiniosis Diagnostics and Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Yersiniosis Diagnostics and Treatment Market is Segmented by Bacterial Species (Yersinia enterocolitica, Yersinia pseudotuberculosis), Product Type (Diagnosis Technique and Therapeutics), Diagnosis Technique (Real-Time PCR, ELISA, Immunoassay, Protein Microarray, Stool Culture, and Other Diagnosis Technique), Therapeutics (Aminoglycosides, Sulfonamides, Cephalosporins, Fluoroquinolones, Tetracyclines, and Other Therapeutics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The report offers the value (in USD million) for the above segments.

Yersiniosis Diagnostics and Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Yersiniosis Diagnostics & Treatment Industry Overview

The Yersiniosis diagnostics and treatment are fragmented in nature due to the presence of several companies operating globally. The major players include Surmodics IVD, Inc, Mikrogen GmbH, CerTest Biotec, Laboratory Corporation of America Holdings, Hologic, Inc, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Thermo Fisher Scientific, Virchow Laboratories Limited, Zhejiang Jinhua CONBA Bio-pharm.

Yersiniosis Diagnostics & Treatment Market Leaders

  1. Surmodics IVD, Inc

  2. Mikrogen GmbH

  3. F. Hoffmann-La Roche Ltd

  4. Laboratory Corporation of America Holdings

  5. CerTest Biotec

  6. *Disclaimer: Major Players sorted in no particular order
Screenshot 2022-07-21 143053.jpg

Global Yersiniosis Diagnostics and Treatment Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?